Ireland· IE-PA-PA1113/018/003
Famvir 500 mg film-coated tablets
A famciclovir product containing famciclovir, registered in Ireland by Phoenix Labs. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Famciclovir is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AB09 (famciclovir), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Famciclovir · ATC J05AB09
12 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of famciclovir costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $15.01 in Italy to $32.07 in Switzerland — a ×2.1 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Famciclovir · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$32.07
- ES Spain$21.31
- FR France$20.36
- IT Italy$15.01
The record
At a glance
HPRA (Ireland)- Active substance
- Famciclovir
- Manufacturer
- Phoenix Labs
- Country
- Ireland (IE)
- ATC code
- J05AB09
- ATC class
- Famciclovir
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1113/018/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
118 interactions on record for famciclovir.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Famciclovir · interactions on record
118 records
- 5 moderate
- 113 info
Most severe, free to view
- PemetrexedL01BA04moderate
- CladribineL01BB04moderate
- Talimogene laherparepvecL01XL02moderate
- Talimogen laherparepvecL01XX51moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Famciclovir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFamciclovirAurobindo Pharma Limited
- ItalyCOIRGENGENETIC S.P.A.
- SpainFAMCICLOVIR PENSA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGTowa Pharmaceutical S.A.
- FinlandAfamcivirGlaxoSmithKline Consumer Healthcare ApS
- NetherlandsFamciclovir Double-e Pharma 500 mg, filmomhulde tablettenDouble-E Pharma Ltd.
- IcelandFamvirPhoenix Labs Unlimited Company
- FranceORAVIR 500 mg, comprimé pelliculéPHOENIX LABS (IRLANDE)
- SwedenFamvir 500 mg Filmdragerad tablettPhoenix Labs Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Famvir
- Cyprus · Famvir
- Germany · Famvir
- Denmark · Famciclovir Viatris, Famvir
- Spain · Famciclovir Normon, Famciclovir Pensa
- Finland · Famvir
- France · Oravir
- United Kingdom (Northern Ireland) · Famciclovir Accord Healthcare, Famciclovir Cadila Pharmaceuticals (Europe)
- Greece · Famcilet, Famvir
- Hungary · Famvir
- Iceland · Famvir
- Italy · Coirgen, Famciclovir Mylan Generics
- Malta · Famvir
- Netherlands · Famciclovir Double-E Pharma, Famciclovir Sandoz
- Sweden · Famvir
- Slovakia · Famciclovir Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ada0cef6-bc21-4e67-b949-99dde17ab7ca GET /v1/drugs/ada0cef6-bc21-4e67-b949-99dde17ab7ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J05AB",
"J05AB09"
],
"strength": null,
"pa_number": "PA1113/018/003",
"substances": [
"Famciclovir"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "17/05/2013",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about famciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.